FT PHARMACEUTICAL & BIOTECHNOLOGY CONFERENCE
The danger of ‘going too far’ with AI
Industry experts dealing with AI services should be showing both devotion to the possibilities opened and skepticism at the same time, says ICON exec.
FT PHARMACEUTICAL & BIOTECHNOLOGY CONFERENCE
Industry experts dealing with AI services should be showing both devotion to the possibilities opened and skepticism at the same time, says ICON exec.
Editas Medicine points to AskBio’s ‘excellent manufacturing facility’ and associated expertise to explain benefits of recent partnership.
FT Pharmaceutical & Biotechnology Conference
Speaking at the FT Pharmaceutical & Biotechnology conference earlier this week, Ipsen’s CCO said that pharma manufacturers need to focus more on the ‘why’.